It has been shown that tumour, node, metastasis (TNM) stage, tumor differentiation, serum laboratory indexes, or immunohistochemical (IHC) staining may be significant prognostic factors for NSCLC treated with EGFR-TKIs (9, 10). Here, EGFR is linked to non-small cell lung carcinoma.